8-K: Bowen Acquisition Corp Faces NASDAQ Delisting Threat Over Delayed Quarterly Report

Bowen Acquisition Corp, a SPAC, has received a non-compliance notice from NASDAQ for failing to timely file its quarterly report, potentially jeopardizing its listing.

Summary

• Bowen Acquisition Corp. (BOWN) received a notice from NASDAQ on May 28, 2025, indicating non-compliance with Listing Rule 5250(c)(1).
• The non-compliance stems from the company's failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
• NASDAQ requires the company to submit a plan to regain compliance by July 28, 2025.
• If the plan is accepted, NASDAQ may grant an extension of up to 180 calendar days, or until November 17, 2025, to file the delinquent report.
• The company is actively working to complete the report and intends to submit a compliance plan if the report is not filed by the July 28, 2025 deadline.
• This notice does not immediately affect the listing of BOWN's securities on NASDAQ.
• The company previously disclosed a definitive agreement for a business combination with Shenzhen Qianzhi BioTechnology Co., Ltd.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the company's non-compliance with NASDAQ listing rules, specifically the failure to file a required quarterly report. This introduces significant regulatory risk and uncertainty regarding the company's continued listing and its ability to complete its business combination, despite management's stated efforts to regain compliance.

Positives

• The non-compliance notice has no immediate effect on the listing of the company's shares on NASDAQ.
• The company is actively working diligently to complete the delinquent report.
• The company intends to file a plan to regain compliance if the report is not filed by the initial deadline.

Negatives

• Bowen Acquisition Corp. is not in compliance with NASDAQ Listing Rule 5250(c)(1) due to the failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
• There is no assurance that the company will be able to regain compliance with NASDAQ listing requirements.
• Failure to regain compliance could lead to delisting from NASDAQ.

Risks

• Risk of delisting from The Nasdaq Stock Market LLC if the company fails to regain compliance with Listing Rule 5250(c)(1) or other NASDAQ listing criteria.
• Inability to complete the delinquent Quarterly Report on Form 10-Q by the July 28, 2025 deadline.
• NASDAQ may not accept the company's plan to regain compliance, or may not grant the full 180-day extension.
• Potential negative impact on the company's ability to complete its previously announced business combination with Shenzhen Qianzhi BioTechnology Co., Ltd. due to listing uncertainty.

Future Outlook

Bowen Acquisition Corp. is diligently working to complete and file its delinquent Form 10-Q. The company intends to submit a plan to NASDAQ by July 28, 2025, if the report is not filed by then, seeking an extension to regain compliance by November 17, 2025. However, there is no assurance that the company will successfully regain compliance or avoid delisting.

Management Comments

• "The Company is continuing to work diligently to complete the Delinquent Report."
• "If the Company is unable to file the Delinquent Report by July 28, 2025, it intends to file a plan to regain compliance with NASDAQ."
• "There can be no assurance, however, that the Company will be able to regain compliance with the listing requirements discussed above or otherwise satisfy the other NASDAQ listing criteria."
• (From Jiangang Luo, CEO): "For investor and media inquiries, please contact: Jiangang Luo Chief Executive Officer jiangangluo@bowenspac.com"

Industry Context

This announcement relates to a Special Purpose Acquisition Company (SPAC), Bowen Acquisition Corp., which is a blank check company formed to effect a business combination. Timely and accurate financial reporting is a fundamental requirement for all publicly traded companies, especially SPACs which are under scrutiny for their operational transparency and ability to complete mergers. Non-compliance with listing rules, particularly regarding financial filings, can severely impact investor confidence and the viability of ongoing business combination efforts, such as BOWN's definitive agreement with Shenzhen Qianzhi BioTechnology Co., Ltd.

Comparison to Industry Standards

• Timely filing of quarterly financial reports (Form 10-Q) is a standard and mandatory requirement for all publicly listed companies on major exchanges like NASDAQ.
• Failure to meet this fundamental reporting obligation, as seen with Bowen Acquisition Corp., is a significant deviation from industry best practices and regulatory expectations.
• Comparable companies, especially other SPACs, are expected to maintain strict adherence to SEC filing deadlines to ensure market transparency and investor protection. For example, other SPACs like Gores Holdings, Churchill Capital Corp, or Pershing Square Tontine Holdings have generally maintained timely filings, setting a benchmark for operational compliance.
• The notice of non-compliance places Bowen Acquisition Corp. in a less favorable position compared to its peers who consistently meet their reporting obligations, potentially impacting its valuation and attractiveness for future transactions or investor capital.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, which could severely impact liquidity and the value of their investment. Uncertainty regarding the company's future and its ability to complete the business combination.
• Potential Merger Target (Shenzhen Qianzhi BioTechnology Co., Ltd.): The non-compliance and potential delisting could jeopardize or delay the definitive business combination agreement, impacting their plans for going public via this SPAC.
• NASDAQ: The exchange is enforcing its listing rules to maintain market integrity and investor confidence.

Next Steps

• Complete and file the delinquent Quarterly Report on Form 10-Q for the quarter ended March 31, 2025.
• If the report is not filed by July 28, 2025, submit a plan to NASDAQ to regain compliance.
• Work towards regaining full compliance with all NASDAQ listing requirements by November 17, 2025, if an extension is granted.

Key Dates

Recommendation

Keywords

Bowen Acquisition Corp, BOWN, NASDAQ, Non-Compliance, Form 10-Q, Delisting, SPAC, Special Purpose Acquisition Company, Quarterly Report, SEC Filing, Regulatory Notice, Business Combination, Shenzhen Qianzhi BioTechnology